推荐产品
方案
≥95% (SDS-PAGE)
表单
liquid
一般描述
Native platelet factor 4 from human platelets. A heparin-binding chemokine released from α-granules of activated platelets. Binds to the newly formed blood vessels and reduces tumor neovascularization. Molecular weight = 7800-9000 (monomer).
外形
In 1.5 M NaCl, 20 mM Tris-HCl, pH 8.3.
制备说明
Prepared from platelets that have been shown by certified tests to be negative for HBsAg and for antibodies to HIV and HCV.
重悬
Following initial thaw, aliquot and freeze (-20°C).
储存分类代码
12 - Non Combustible Liquids
WGK
WGK 2
闪点(°F)
Not applicable
闪点(°C)
Not applicable
法规信息
监管及禁止进口产品
M Cortellaro et al.
Thrombosis research, 58(6), 571-576 (1990-06-15)
The role of platelet activation in diabetic microangiopathy is still controversial. We evaluated the degree of platelet activation in relation to vessel wall damage in three selected, well matched groups of subjects (10 healthy controls; 20 insulin dependent diabetic patients
Stephanie Pitsilos et al.
Thrombosis and haemostasis, 90(6), 1112-1120 (2003-12-04)
Emerging evidence supports a role for platelets in the progression of atherosclerosis in addition to an involvement in thrombotic vascular occlusion. Platelet Factor 4 (PF4), a chemokine released by activated platelets, stimulates several pro-atherogenic processes. Therefore, we examined the localization
D L Kolber et al.
Journal of the National Cancer Institute, 87(4), 304-309 (1995-02-15)
When administered locally, recombinant platelet factor 4 (rPF4), a known angiogenesis inhibitor, has been shown to effectively suppress murine melanoma and human colon carcinoma primary tumor growth in mice. It was tentatively concluded that this effect was due to the
C Ravanat et al.
European journal of biochemistry, 223(1), 203-210 (1994-07-01)
Platelet factor 4 is a heparin-binding protein released from the alpha granules of activated platelets. This study describes the purification and identification of two forms of rat platelet factor 4, the previously characterized non-glycosylated form of 7 kDa and an
Y Sato et al.
Biochemical and biophysical research communications, 172(2), 595-600 (1990-10-30)
Platelet factor 4 (PF-4) blocked the binding of basic fibroblast growth factor (bFGF) to the plasma membrane receptor. Five micrograms/ml of PF-4 completely blocked the specific binding of bFGF to the receptor of NIH 3T3 cells. Endogenously produced bFGF regulates
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系技术服务部门